-
DNA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ginkgo Bioworks (DNA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 661.54 mm | 661.54 mm | 661.54 mm | 661.54 mm | 661.54 mm | 661.54 mm |
Cash burn (monthly) | 38.07 mm | 36.09 mm | 18.93 mm | 55.80 mm | 34.50 mm | 27.92 mm |
Cash used (since last report) | 153.12 mm | 145.16 mm | 76.13 mm | 224.45 mm | 138.77 mm | 112.28 mm |
Cash remaining | 508.42 mm | 516.37 mm | 585.41 mm | 437.09 mm | 522.77 mm | 549.26 mm |
Runway (months of cash) | 13.4 | 14.3 | 30.9 | 7.8 | 15.2 | 19.7 |
13F holders | Current |
---|---|
Total holders | 152 |
Opened positions | 29 |
Closed positions | 188 |
Increased positions | 1 |
Reduced positions | 117 |
13F shares | Current |
---|---|
Total value | 212.84 bn |
Total shares | 178.05 mm |
Total puts | 683.98 k |
Total calls | 1.11 mm |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Cascade Investment, L.L.C. | 151.87 mm | $1.73 bn |
Viking Global Investors | 3.58 mm | $29.15 bn |
Baillie Gifford & Co | 3.36 mm | $27.37 bn |
Vanguard | 2.61 mm | $21.24 bn |
Anchorage Capital Group, L.L.C. | 1.75 mm | $14.23 bn |
LGEN Legal & General | 1.43 mm | $11.57 bn |
BlackRock | 1.09 mm | $8.85 bn |
D. E. Shaw & Co. | 872.65 k | $7.11 bn |
Opaleye Management | 820.20 k | $6.68 bn |
Two Sigma Advisers | 807.22 k | $6.58 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jan 25 | Mark E. Dmytruk | Class A Common Stock | Sell | Dispose S | No | No | 11.718 | 645 | 7.56 k | 33,216 |
6 Jan 25 | Steven P. Coen | Class A Common Stock | Sell | Dispose S | No | No | 11.718 | 324 | 3.80 k | 7,288 |
3 Jan 25 | Mark E. Dmytruk | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 572 | 0.00 | 33,861 |
3 Jan 25 | Mark E. Dmytruk | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 453 | 0.00 | 33,289 |
3 Jan 25 | Mark E. Dmytruk | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 450 | 0.00 | 32,836 |
3 Jan 25 | Mark E. Dmytruk | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 572 | 0.00 | 21,776 |
3 Jan 25 | Mark E. Dmytruk | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 453 | 0.00 | 11,782 |
3 Jan 25 | Mark E. Dmytruk | RSU Class A Common Stock | Option exercise | Dispose M | No | No | 0 | 450 | 0.00 | 5,430 |
3 Jan 25 | Steven P. Coen | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 156 | 0.00 | 7,612 |
3 Jan 25 | Steven P. Coen | Class A Common Stock | Option exercise | Acquire M | No | No | 0 | 587 | 0.00 | 7,456 |